Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | CYP2U1 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → CYP2U1 |
| (<<) BBC3 → CYP2U1 |
| (<<) BMP8B → CYP2U1 |
| (<<) CDK5 → CYP2U1 |
| (<<) CDK6 → CYP2U1 |
| (<<) CREB1 → CYP2U1 |
| (<<) CSGALNACT2 → CYP2U1 |
| (<<) DDX18 → CYP2U1 |
| (<<) DNAJA1 → CYP2U1 |
| (<<) EPHB3 → CYP2U1 |
| (<<) FZD4 → CYP2U1 |
| (<<) GYS1 → CYP2U1 |
| (<<) HS2ST1 → CYP2U1 |
| (<<) HS3ST2 → CYP2U1 |
| (<<) HSP90AB1 → CYP2U1 |
| (<<) IVL → CYP2U1 |
| (<<) KIAA1199 → CYP2U1 |
| (<<) MAP3K11 → CYP2U1 |
| (<<) MCL1 → CYP2U1 |
| (<<) MPP1 → CYP2U1 |
| (<<) MTMR6 → CYP2U1 |
| (<<) NFIL3 → CYP2U1 |
| (<<) PRKCH → CYP2U1 |
| (<<) PTEN → CYP2U1 |
| (<<) RNF111 → CYP2U1 |
| (<<) RTN3 → CYP2U1 |
| (<<) SGSH → CYP2U1 |
| (<<) SLC25A37 → CYP2U1 |
| (<<) SOCS3 → CYP2U1 |
| (<<) SOD2 → CYP2U1 |
| (<<) SPR → CYP2U1 |
| (<<) STAM2 → CYP2U1 |
| (<<) STK4 → CYP2U1 |
| (<<) SULT4A1 → CYP2U1 |
| (<<) TRAF1 → CYP2U1 |
| (<<) VEGFB → CYP2U1 |
| Downstream (Children) |
|---|
| CYP2U1 → ARHGAP10 (>>) |
| CYP2U1 → AVP (>>) |
| CYP2U1 → CDC42EP2 (>>) |
| CYP2U1 → FNDC4 (>>) |
| CYP2U1 → GDNF (>>) |
| CYP2U1 → MAPK8 (>>) |
| CYP2U1 → NEUROG1 (>>) |
| CYP2U1 → NFATC4 (>>) |
| CYP2U1 → RGS20 (>>) |
| CYP2U1 → SMAD1 (>>) |
| CYP2U1 → SPRY4 (>>) |
| CYP2U1 → TMC7 (>>) |
